logo

For the Inventor, By the Inventor

Taipei, Taiwan

Ann Chen

This inventor holds 17 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignees: National Defense Medical Center, Academia Sinica, National Defense Medical University. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ann Chen. Retrieved from https://idiyas.com/inventor/ann-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 47.1

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal11 out of 50 
 
National Defense Medical Center
 patents
silverMedal1 out of 726 
 
Academia Sinica
 patents
bronzeMedal1 out of 2 
 
National Defense Medical University
 patents
4. 1 out of 1 
 
Wellhead Biological Technology Corp.
 patent
5. 3 out of 834,513 
Other
 patents

Years Active: 2012-2026

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 12650431 - Human IgG autoantibodies against galactose-deficient IgA1, preparation method thereof, and use thereof (2026-06-09),
2. 12478632 - Method for ameliorating progression of renal fibrosis and treating renal fibrosis by 5-(2',4′-difluorophenyl)-salicylanilide derivatives (2025-11-25),
3. 12090132 - Tris DBA pharmaceutical composition and its use for treating autoimmune diseases (2024-09-17),
4. 12000841 - Diagnostic kits and methods configured to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in the subject of IgA nephropathy (2024-06-04),
5. 10357507 - Use of ginsenoside M1 for inhibiting renal fibrosis (2019-07-23),
6. 10172876 - Use of ginsenoside M1 for treating IgA nephropathy (2019-01-08),
7. 9844560 - Use of ginsenoside M1 for treating lupus nephritis (2017-12-19),
8. 9475789 - Use of polyenylpyrrole derivatives for treating inflammation (2016-10-25),
9. 9393226 - Use of osthole for treating focal segmental glomerulosclerosis (2016-07-19),
10. 9321795 - Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritis (2016-04-26),
11. 8993637 - Use of citral for treating focal segmental glomerulosclerosis (2015-03-31),
12. 8785137 - Method for renal disease diagnosis using Rab23 as marker (2014-07-22),
13. 8518461 - Use of bamboo vinegar for treating inflammation (2013-08-27),
14. 8414938 - [object Object] (2013-04-09),
15. 8329651 - Method for renal disease diagnosis and prognosis using annexin A1 and Rab23 as markers (2012-12-11),

Title: Ann Chen: Innovator in Pharmaceutical Composition and Diagnostic Methods

Introduction

Ann Chen is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of pharmaceuticals and diagnostics, holding a total of 15 patents. Her work focuses on innovative solutions for treating autoimmune diseases and improving diagnostic methods for IgA nephropathy.

Latest Patents

Among her latest patents is a pharmaceutical composition that utilizes Tris (dibenzylideneacetone) dipalladium (Tris DBA) for treating autoimmune diseases. This invention provides a new use for Tris DBA, offering potential treatments for conditions such as multiple sclerosis, psoriasis, asthma, systemic lupus erythematosus, and lupus nephritis. Additionally, she has developed diagnostic kits and methods designed to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in patients suffering from IgA nephropathy. This invention includes a lectin-based diagnostic reagent and a method for detecting Gd-IgA1 using specific isolates.

Career Highlights

Ann Chen has worked at the National Defense Medical Center, where she has contributed to various research projects and innovations. Her expertise in pharmaceutical compositions and diagnostics has positioned her as a key figure in her field.

Collaborations

Throughout her career, Ann has collaborated with notable colleagues, including Shuk-Man Ka and Kuo-Feng Hua. These partnerships have enhanced her research and development efforts, leading to impactful inventions.

Conclusion

Ann Chen's innovative work in pharmaceuticals and diagnostics showcases her dedication to advancing medical science. Her contributions have the potential to improve treatment options for autoimmune diseases and enhance diagnostic accuracy for IgA nephropathy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…